{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-026820","form_type":"8-K","ticker":null,"cik":"0001622879","company_name":"Medicine Man Technologies, Inc.","filed_at":"2024-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.844776+00:00","generated_at":"2026-06-05T17:08:43.065422+00:00","sec_items":["1.01","5.02","1.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Schwazze CEO Krishnamurthy resigns; CFO Hoffmaster named interim CEO","bullets":["CEO Nirup Krishnamurthy resigned Feb 20, 2024 for personal reasons; no disagreement.","Separation agreement: 8 months severance at current base salary plus COBRA coverage.","CFO Forrest Hoffmaster appointed interim CEO effective Feb 21, 2024.","Hoffmaster's base salary increased from $360k to $400k; eligible for $240k bonus in 6 months.","Board to search for permanent CEO and a replacement director following Krishnamurthy's departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-026820","json":"https://secwatch.observer/filing/0001104659-24-026820.json","markdown":"https://secwatch.observer/filing/0001104659-24-026820.md","text":"https://secwatch.observer/filing/0001104659-24-026820.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622879/000110465924026820/0001104659-24-026820-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622879/000110465924026820/tm246956d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T17:08:43.065422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1921832469","claim":"Forrest Hoffmaster was appointed as interim Chief Executive Officer at Medicine Man Technologies, Inc..","evidence_excerpt":"On February 21, 2024 (“Appointment Date”), the Board appointed Forrest Hoffmaster, the Company’s Chief Financial Officer, as interim Chief Executive Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622879/000110465924026820/0001104659-24-026820-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"1a84ae4c8e","claim":"Nirup Krishnamurthy resigned as Chief Executive Officer at Medicine Man Technologies, Inc..","evidence_excerpt":"On February 20, 2024, the Company received notice of the resignation of Nirup Krishnamurthy as a member of the Company’s board of directors (the “Board”) and Chief Executive Officer of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622879/000110465924026820/0001104659-24-026820-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"aa10df6f8c","claim":"Nirup Krishnamurthy resigned as Director at Medicine Man Technologies, Inc..","evidence_excerpt":"resignation of Nirup Krishnamurthy as a member of the Company’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622879/000110465924026820/0001104659-24-026820-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}